P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases
Takato Takenouchi1, Kazunari Sekiyama, Akio Sekigawa
1Laboratory for Chemistry and Metabolism, Tokyo Metropolitan Institute for Neuroscience, Fuchu, Tokyo 183-8526, Japan.
Abstract:
A recent study suggested that neuroinflammation plays a major role in the pathogenesis of a number of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Although the precise mechanism is obscure, dysregulation of the signaling transduction pathway in microglia may enhance inflammation, leading to synaptic dysfunction and ultimately to neuronal cell death. The expression and function of the P2X7 receptor (P2X7R), an ATP-gated ion channel abundantly expressed in microglia in the brain, is significantly up-regulated in the postmortem brain of Alzheimer's disease patients and various neurodegenerative disease animal models. This supports the role of the P2X7R pathway in the progression of neurodegeneration. Blocking P2X7R using brilliant blue G, a P2X7R antagonist that can cross the blood-brain barrier, has been shown to result in the amelioration of neuropathology in various animal models. Taken together, these results raise the possibility that the P2X7R signaling pathway could be a therapeutic target for treating various neurodegenerative diseases.
Insights
Neuroinflammation contributes to neurodegenerative diseases like Alzheimer's. Targeting the P2X7 receptor (P2X7R) pathway in microglia shows promise for therapeutic intervention in these conditions.
Area of Science:
- Neuroscience
- Immunology
Background:
- Neuroinflammation is implicated in neurodegenerative diseases.
- Microglial signaling pathway dysregulation may drive neuroinflammation, synaptic dysfunction, and neuronal death.
- The P2X7 receptor (P2X7R) is upregulated in Alzheimer's disease and neurodegenerative models.
Purpose of the Study:
- To investigate the role of the P2X7 receptor (P2X7R) signaling pathway in neurodegeneration.
- To explore P2X7R as a potential therapeutic target for neurodegenerative diseases.
Main Methods:
- Examined P2X7R expression and function in postmortem Alzheimer's disease brains and animal models.
- Utilized brilliant blue G, a P2X7R antagonist, in animal models of neurodegeneration.
Main Results:
- P2X7R expression and function are significantly upregulated in Alzheimer's disease and neurodegenerative models.
- Blocking P2X7R with brilliant blue G ameliorated neuropathology in animal models.
Conclusions:
- The P2X7R signaling pathway plays a significant role in the progression of neurodegeneration.
- P2X7R antagonism presents a potential therapeutic strategy for neurodegenerative diseases.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Parkinson Disease ll: Pathophysiology
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Parkinson's Disease: Overview
GPCR Desensitization

